Don’t miss the latest developments in business and finance.

Chinese firm gets approval to begin human testing for coronavirus vaccine

The potential vaccine has received a certificate from the National Medical Products Administration to launch clinical trials

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Chinese researchers and companies are testing six experimental shots in humans
Reuters New Delhi
1 min read Last Updated : Jun 23 2020 | 3:02 PM IST
China has approved a coronavirus vaccine candidate developed by Chongqing Zhifei Biological Products' unit to begin human testing, the company said in a filing on Tuesday.

The potential vaccine, co-developed by Anhui Zhifei Longcom Biopharmaceutical and the Institute of Microbiology of the Chinese Academy of Sciences, has received a certificate from the National Medical Products Administration to launch clinical trials.

Chinese researchers and companies are testing six experimental shots in humans, and more than a dozen vaccines are in different stages of clinical trials globally against the virus that has killed over 470,000 people.


However, none of the them have passed large-scale, late-stage phase 3 clinical trials, a necessary step before entering the consumer market.

Topics :CoronavirusChinapharmaceutical sectorclinical trialsCoronavirus Vaccine